|
Pharma World 2005
February 24-27, 2005; Bandra Kurla Complex, Mumbai
Clinical research for trials in all three phases is a key growth area for reliable
outsourcing and partnership. This is by virtue of India's vastly diverse ethnic
patient base. With this, an entire gamut of clinical research activities and
services open up for scientifically qualified personnel from pure science, the
biological sciences, pharmacy and medicine. Taking these into perspective, Express
Pharma Pulse, India's leading publication for the industry is organising Pharma
Research Confluence, a unique platform focusing on the key trends, vital issues
and emerging opportunities facing the Clinical and Pre-Clinical segments today.
The confluence will offer a bird's eye view of the industry's achievements from
both an Indian and international perspective and showcase the spectrum of activities
in drug development. Being held between February 24-27, 2005, at the Bandra
Kurla Commercial Complex, Mumbai, Pharma Research Confluence offers a valuable
exchange of insights, case studies and learnings for all in attendance.
*Seminar on Pre-Clinical Research
(February 24-25, 2005)
Topic
* Drug Discovery & Development: Trends Post 2005
Dr J M Khanna, President, Life Sciences, Jubilant Organosys Ltd
* Intellectual Property and Revenue Protection
Dr Prabuddha Ganguli, CEO, Vision IPR
* Risk management and Insurance in the Pharmaceutical
Industry
Andrew Clarke, Executive Vice President, Corporate Broking, Aon Global Insurance
* Role of Chemical Development in Drug Development
S Mahender Rao, General Manager, Orchid Pharmaceuticals Ltd
* Role of Pharmacokinetics in Drug Discovery
Dr Anisha Pargal, Technical head, Hindustan Lever Limited
* Preclinical Toxicology Evaluation
Dr M R Marathe, Head - Toxicology, Sun Pharma Research Centre
* Lead Optimisation
Dr Laxmikant Gharat, Senior Principal Scientist, Glenmark
Research Centre
* Selection of Right Therapeutic Targets
Dr M Padigaru, Senior Principal Scientist, Nicholas Piramal Research Centre
*Seminar on Advanced Clinical Research and GCP Workshop
(February 26-27, 2005)
Topic
* Introduction
Dr Arun Bhatt, President, Clin Invent Research Pvt Ltd
* GCP Review & Quiz
Dr Umakanta Sahoo, General Manager, Chiltern International
* Adverse Events Management
Sanjay Sane, Senior Manager, Novartis India Ltd
* Monitoring - Source Data Verification
Dr Umakanta Sahoo, General Manager, Chiltern International
* Protocol Planning
Dr Arun Bhatt, President, Clin Invent Research Pvt Ltd
* SOPs - Concepts, Preparation
Gopalkrishna Pai, Operations Manager, Omnicare
* Protocol Group Exercise
Dr Arun Bhatt, President, Clin Invent Research Pvt Ltd
* IT and Future of Clinical Trials
Dr Anjan Basu, Head, Life Science, Siemens Information Systems
* Informed Consent Process
Shashikant Bhat, Manager, Clinical Quality Assurance, SIRO Clinpharm Pvt Ltd
Rupesh Patki, SIRO Clinpharm Pvt Ltd
Exhibition
In concert with the Seminars which bring together the nation's leading research
and development companies and professionals onto a common platform, Pharma Research
Confluence will present an exclusive, highly focused Exhibition with a captive
audience (seminar attendees) comprising the industry's key decision makers.
|
